Search results
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Reuters via Yahoo Finance Canada· 5 hours ago(Reuters) -Sanofi on Thursday raised its full-year profit outlook after strong demand for...
Sanofi Lifts Earnings Outlook as Blockbuster Dupixent Sees Record Demand
Bloomberg· 5 hours agoSanofi lifted its earnings forecast for the year and posted earnings that topped estimates amid...
Sanofi: Q2 Earnings Snapshot
Associated Press Finance via Yahoo Finance Canada· 33 minutes agoPARIS (AP) — PARIS (AP) — Sanofi (SNY) on Thursday reported second-quarter earnings of $1.2 billion. On a per-share basis, the company said it had profit of 48 cents. Earnings ...
Europe’s Biggest Drugmakers Raise Guidance on New Product Demand
Bloomberg· 2 hours agoBig European drugmakers lifted their financial guidance as a focus on new, innovative drugs helped stimulate sales.
Morning Bid: Stock rout spreads beyond tech
Reuters via Yahoo Finance Canada· 6 hours agoThe global equity sell-off looks set to extend into Europe on Thursday although the region may be spared the carnage in parts of Asia, where Japan's...
Roche lifts 2024 profit guidance on strong drug sales
Reuters via Yahoo Finance Canada· 5 hours agoFRANKFURT (Reuters) -Roche on Thursday raised its full-year earnings forecast after exceeding...
Analysis-Drug giants eye China for deals despite growing Sino-US tensions
Reuters via Yahoo Finance Canada· 2 days agoBristol Myers Squibb and Sanofi are also hunting for deals, according to company employees, even as...
Biden's speech, Ford's miss, European earnings - what's moving markets
Investing.com via Yahoo Finance Canada· 6 hours agoThe tech-led selloff looks set to continue Thursday, while Ford has also disappointed with a second-quarter profit miss. President Joe Biden addressed the nation on Wednesday for the first time ...
The global M&A market’s big-deal bravado is losing steam as rates stay high in 2024
Fortune via Yahoo Finance Canada· 2 days agoHowever, some of this year’s transactions fell apart at the first hurdle, as shareholders started to...
Merck's RSV shot helps protect infants in mid-to-late stage study
Reuters via Yahoo Canada News· 2 days ago(Reuters) -Merck's antibody-based shot met the main goal of a mid-to-late stage trial, when tested...
